Kazunori Suzuki

Publication Activity (10 Years)

Years Active: 2018-2018
Publications (10 Years): 2

Top Topics

Combination Therapy

Chemotherapy Induced

Top Venues

CNS neuroscience & therapeutics

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Kazunori Suzuki, Akina Harada, Hirobumi Suzuki, Clizia Capuani, Annarosa Ugolini, Mauro Corsi, Haruhide Kimura
Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents. Pharmacology research & perspectives 6 (1) (2018)
Kazunori Suzuki, Haruhide Kimura
TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia. CNS neuroscience & therapeutics 24 (7) (2018)